Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dey settles AWP litigation

Executive Summary

Merck KGaA subsidiary Dey reaches Medicaid reimbursement settlements with Nevada and Hawaii (March 29 and March 21, respectively) regarding alleged misrepresentations of average wholesale price. Dey will pay $670,000 to Nevada and $946,992 to Hawaii. In 2004, Dey paid $18.5 million to settle a Medicare fraud suit brought by the attorney general of Texas, and currently has suits in several states (1"The Pink Sheet" Feb. 12, 2007, p. 23)...

You may also be interested in...

Sanofi Is Fifth Company To Sign AWP Settlement With DoJ, Pays $190 Mil.

While dozens of pharmaceutical companies are entangled in fraudulent pricing lawsuits, only five have inked a deal with the Department of Justice

AWP Litigation Increases As Justice Dept. Sues Roxane For Price Inflation

Another lawsuit has been added to the tangle of litigation over average wholesale drug pricing

ViiV Anticipates 10%-15% Switchover To Long-Term HIV Option Cabenuva

The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts